BMRN
☆
EPS:
0.54
Rev:
766M
Net Inc:
106M
💾
💾
💾
💾
💾
Income Statement
Balance Sheet
Cash Flow
Revenue
vs Industry
Valuation
Overview
Income Statement
💾
Expenses
💾
Assets
💾
Assets (Current)
💾
Assets (Non-Current)
💾
Liabilities
💾
Liabilities (Current)
💾
Liabilities (Non-Current)
💾
Cash Flow
💾
Cash Flow Investing
💾
Dimension Breakdowns
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
srt:ProductOrServiceAxis
Leaf Members
💾
srt:ProductOrServiceAxis, srt:StatementGeographicalAxis, us-gaap:ContractWithCustomerSalesChannelAxis
Leaf Members
💾
srt:ProductOrServiceAxis, us-gaap:ContractWithCustomerSalesChannelAxis
Leaf Members
💾
BMRN vs
Biotechnology
(37 peers) - Healthcare
Gross Margin
77.7%
-0.4pp vs peers
Operating Margin
12.7%
-24.0pp vs peers
Net Margin
10.8%
-19.2pp vs peers
Gross Margin
Operating Margin
Net Margin
💾
Dimension Breakdowns
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis
Leaf Members
💾
Related:
REGN
INCY
VRTX
CPRX
UTHR
ALKS
JAZZ
MRNA
PTCT
APLS